Letter re: Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
医学
打开标签
随机对照试验
乳腺癌
肿瘤科
内科学
癌症
作者
X. Zeng,Hao Sun,Y. Wang
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2025-03-31卷期号:36 (7): 838-838被引量:1